455 related articles for article (PubMed ID: 12913240)
1. Hydroxypropyl methylcellulose based cephalexin extended release tablets: influence of tablet formulation, hardness and storage on in vitro release kinetics.
Saravanan M; Sri Nataraj K; Ganesh KS
Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):978-83. PubMed ID: 12913240
[TBL] [Abstract][Full Text] [Related]
2. The effect of tablet formulation and hardness on in vitro release of cephalexin from Eudragit L100 based extended release tablets.
Saravanan M; Nataraj KS; Ganesh KS
Biol Pharm Bull; 2002 Apr; 25(4):541-5. PubMed ID: 11995942
[TBL] [Abstract][Full Text] [Related]
3. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M
Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
[TBL] [Abstract][Full Text] [Related]
4. Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design.
Khanvilkar KH; Huang Y; Moore AD
Drug Dev Ind Pharm; 2002 May; 28(5):601-8. PubMed ID: 12098849
[TBL] [Abstract][Full Text] [Related]
5. Does the performance of wet granulation and tablet hardness affect the drug dissolution profile of carvedilol in matrix tablets?
Košir D; Ojsteršek T; Vrečer F
Drug Dev Ind Pharm; 2018 Sep; 44(9):1543-1550. PubMed ID: 29848075
[TBL] [Abstract][Full Text] [Related]
6. Release Kinetics of Hydroxypropyl Methylcellulose Governing Drug Release and Hydrodynamic Changes of Matrix Tablet.
Park C; Lee JH; Jin G; Ngo HV; Park JB; Tran TTD; Tran PHL; Lee BJ
Curr Drug Deliv; 2022; 19(5):520-533. PubMed ID: 34420504
[TBL] [Abstract][Full Text] [Related]
7. Formulation and in vitro, in vivo evaluation of effervescent floating sustained-release imatinib mesylate tablet.
Kadivar A; Kamalidehghan B; Javar HA; Davoudi ET; Zaharuddin ND; Sabeti B; Chung LY; Noordin MI
PLoS One; 2015; 10(6):e0126874. PubMed ID: 26035710
[TBL] [Abstract][Full Text] [Related]
8. Characterization of 5-fluorouracil release from hydroxypropylmethylcellulose compression-coated tablets.
Wu B; Shun N; Wei X; Wu W
Pharm Dev Technol; 2007; 12(2):203-10. PubMed ID: 17510892
[TBL] [Abstract][Full Text] [Related]
9. Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation.
Reddy KR; Mutalik S; Reddy S
AAPS PharmSciTech; 2003 Dec; 4(4):E61. PubMed ID: 15198556
[TBL] [Abstract][Full Text] [Related]
10. Influence of hydroxypropyl methylcellulose polymer on in vitro and in vivo performance of controlled release tablets containing alprazolam.
Mahaguna V; Talbert RL; Peters JI; Adams S; Reynolds TD; Lam FY; Williams RO
Eur J Pharm Biopharm; 2003 Nov; 56(3):461-8. PubMed ID: 14602191
[TBL] [Abstract][Full Text] [Related]
11. Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release.
Hiremath PS; Saha RN
Drug Deliv; 2008; 15(3):159-68. PubMed ID: 18379928
[TBL] [Abstract][Full Text] [Related]
12. Captopril floating and/or bioadhesive tablets: design and release kinetics.
Nur AO; Zhang JS
Drug Dev Ind Pharm; 2000 Sep; 26(9):965-9. PubMed ID: 10914320
[TBL] [Abstract][Full Text] [Related]
13. Development of sustained-release matrix tablets of BKP-01-041 (tilorone derivative) containing Hypromellose.
Chen L; Wang F
Pharmazie; 2013 Oct; 68(10):796-9. PubMed ID: 24273882
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
[TBL] [Abstract][Full Text] [Related]
15. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
[TBL] [Abstract][Full Text] [Related]
16. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
Košir D; Vrečer F
Drug Dev Ind Pharm; 2017 Feb; 43(2):329-337. PubMed ID: 27739880
[TBL] [Abstract][Full Text] [Related]
17. Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride.
Gil EC; Colarte AI; Bataille B; Pedraz JL; Rodríguez F; Heinämäki J
Int J Pharm; 2006 Jul; 317(1):32-9. PubMed ID: 16584856
[TBL] [Abstract][Full Text] [Related]
18. Study of the influence of cellulose derivatives on physical and analytical attributes of a drug product belonging to BCS class II.
Domosławska M; Pawlak-Morka R; Dobrzyński Ł; Herda M
Polim Med; 2018; 48(2):83-90. PubMed ID: 31111692
[TBL] [Abstract][Full Text] [Related]
19. Core-in-cup tablet design of metoprolol succinate and its evaluation for controlled release.
Nagaraju R; Meera DS; Kaza R; Arvind VV; Venkateswarlu V
Curr Drug Discov Technol; 2009 Dec; 6(4):299-305. PubMed ID: 20025598
[TBL] [Abstract][Full Text] [Related]
20. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.
Park JB; Lim J; Kang CY; Lee BJ
Curr Drug Deliv; 2013 Dec; 10(6):732-41. PubMed ID: 23855499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
